Scarica l'app Stockscreener
0.148
7.25%
0.010
Dopo l'orario di chiusura:
.14
-0.008
-5.41%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché AXDX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.138
Aprire:
$0.13
Volume 24 ore:
3.93M
Relative Volume:
17.66
Capitalizzazione di mercato:
$13.40M
Reddito:
$12.00M
Utile/perdita netta:
$-63.23M
Rapporto P/E:
-0.0247
EPS:
-6
Flusso di cassa netto:
$-43.02M
1 W Prestazione:
-72.08%
1M Prestazione:
-75.21%
6M Prestazione:
-91.91%
1 anno Prestazione:
-82.99%
Intervallo 1D:
$0.125
$0.164
Intervallo di 1 settimana:
$0.117
$0.5599
Portata 52W:
$0.117
$2.09
Accelerate Diagnostics Inc Stock (AXDX) Company Profile
Nome
Accelerate Diagnostics Inc
Settore
Industria
Telefono
303-863-8088
Indirizzo
3950 S. COUNTRY CLUB ROAD #470, TUCSON, AZ
Confronta AXDX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AXDX
Accelerate Diagnostics Inc
|
0.148 | 13.40M | 12.00M | -63.23M | -43.02M | -6.00 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Accelerate Diagnostics Inc Stock (AXDX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-03-09 | Downgrade | Craig Hallum | Buy → Hold |
| 2020-10-08 | Iniziato | BTIG Research | Neutral |
| 2020-08-07 | Aggiornamento | Craig Hallum | Hold → Buy |
| 2019-09-27 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-11-07 | Downgrade | JP Morgan | Overweight → Neutral |
| 2018-05-24 | Iniziato | Craig Hallum | Hold |
| 2017-12-13 | Downgrade | BTIG Research | Buy → Neutral |
| 2017-07-12 | Ripresa | BTIG Research | Buy |
| 2016-03-24 | Iniziato | JP Morgan | Overweight |
| 2015-12-16 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Accelerate Diagnostics Inc Borsa (AXDX) Ultime notizie
Accelerate Diagnostics files for Chapter 11 bankruptcy, seeks asset sale amid financial strain - The Business Journals
Post-Trade Analysis: Accelerate Diagnostics Inc (AXDX) Slides -70.39, Closing at 0.14 - DWinneX
Accelerate Diagnostics initiates Chapter 11 and asset sale By Investing.com - Investing.com Nigeria
Accelerate Diagnostics Files for Chapter 11 Bankruptcy - TipRanks
Accelerate Diagnostics files for Chapter 11 - USA Herald
Biotech Co. Accelerate Diagnostics Hits Ch. 11 With Sale Plan - Law360
Accelerate Diagnostics Files For Chapter 11 Protection And Agrees To Terms To Sell Substantially All Assets - marketscreener.com
Accelerate Diagnostics (AXDX) Starts Chapter 11 for Asset Sale | - GuruFocus
Accelerate Diagnostics Initiates Chapter 11 Restructuring Proceeding - Nasdaq
Accelerate Diagnostics Files for Chapter 11 Protection and Agrees to Terms to Sell Substantially All Assets - Stock Titan
Accelerate Diagnostics files for Chapter 11 bankruptcy - marketscreener.com
Motion for Joint Administration Filed by Accelerate Diagnostics, Inc. - marketscreener.com
Accelerate Diagnostics, Inc. Filed for Bankruptcy - marketscreener.com
Renaissance Technologies LLC Grows Position in Accelerate Diagnostics, Inc. (NASDAQ:AXDX) - Defense World
Accelerate Diagnostics (NASDAQ:AXDX) Earns Hold Rating from Analysts at StockNews.com - Defense World
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Short Interest Update - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Raymond James Has Negative Forecast for TSE:BEI Q1 Earnings - The AM Reporter
Accelerate Diagnostics, Inc. to Host Earnings Call - ACCESS Newswire
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated at StockNews.com - Defense World
StockNews.com Begins Coverage on Accelerate Diagnostics (NASDAQ:AXDX) - Defense World
Accelerate Diagnostics grants CEO retention bonus - Investing.com Australia
Accelerate Diagnostics grants CEO retention bonus By Investing.com - Investing.com Canada
Accelerate Diagnostics CEO Retention Bonus Agreement - TipRanks
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Sees Significant Decrease in Short Interest - Defense World
Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs - The Manila Times
Renovaro Secures High-Powered Computing from Nebul Through - GlobeNewswire
Accelerate Diagnostics (NASDAQ:AXDX) Coverage Initiated by Analysts at StockNews.com - Defense World
Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight - GlobeNewswire
Accelerate Diagnostics adds new independent directors - Investing.com Australia
Accelerate Diagnostics adds new independent directors By Investing.com - Investing.com Canada
Accelerate Diagnostics (AXDX) Appoints New Directors and Forms S - GuruFocus
Accelerate Diagnostics Appoints New Independent Directors - TipRanks
Accelerate Diagnostics board forms committee to exlore strategic alternatives - TipRanks
Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - Yahoo Finance
Accelerate Diagnostics CTO sells shares worth $989 By Investing.com - Investing.com UK
Accelerate Diagnostics CTO sells shares worth $989 - Investing.com
Accelerate Diagnostics CEO Jack Phillips sells $16,472 in stock - Investing.com
Accelerate Diagnostics CEO Sells Shares to Cover Tax Obligations - TradingView
AXDX stock touches 52-week low at $0.63 amid market challenges - Investing.com India
Microbial Identification Methods Market Forecasted to Grow at 6.64% CAGR, Reaching $8.16 Billion by 2030The Insight Partners - Yahoo Finance
Automotive Diagnostics Scanner Market to Accelerate Growth with Actron, Denso, Launch Tech - newstrail.com
Accelerate Diagnostics CFO sells shares worth $4,839 By Investing.com - Investing.com South Africa
Accelerate Diagnostics CFO sells shares worth $4,839 - Investing.com
Accelerate Diagnostics (NASDAQ:AXDX) Shares Pass Below 200 Day Moving Average – What’s Next? - Defense World
AXDX stock touches 52-week low at $0.73 amid market challenges By Investing.com - Investing.com South Africa
AXDX stock touches 52-week low at $0.73 amid market challenges - Investing.com Australia
Accelerate Diagnostics Inc Azioni (AXDX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):